Alphavirus rna replicon systems
CA 2220964 C · Owner: Davis, Nancy L. · Inventors: Johnston, Robert E.; Smith, Jonathan F.; Parker, Michael
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a helper cell for expressing an infectious replication defective, alphavirus particle in an alphavirus-permissive cell. The helper cell includes (a) a first helper RNA encoding (i) at least one alphavirus structural protein, and (ii) not encoding at least one alphavirus structural protein; and (b) a second helper RNA separate from the first helper RNA, the second helper RNA (i) not encoding the alphavirus structural protein encoded by the first helper RNA, and (ii) encoding the at least one alphavirus structural protein not encoded by the first helper RNA. Preferably the helper , cell is co-transfected with a replicon RNA encoding an alphavirus packaging …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 21, 1996 and granted September 13, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 21, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 21, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.